Key result
IV amiodarone achieves ~78% efficacy without worsening function in heart failure with rapid AF.
Why the study?
The efficacy and safety of intravenous amiodarone for atrial fibrillation with rapid ventricular response in patients with congestive heart failure needed evaluation.
Does intravenous amiodarone improve clinical response in patients with congestive heart failure and atrial fibrillation with rapid ventricular response?
Does intravenous amiodarone improve clinical response in patients with congestive heart failure and atrial fibrillation with rapid ventricular response?
Intravenous amiodarone is effective and safe for managing atrial fibrillation with rapid ventricular response in patients with congestive heart failure.
Answers are grounded in this paper and cite their sources.
May support acute rate control with IV amiodarone in HF-AF; hypothesis-generating and leaves open need for randomized confirmation.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
程祖亨 et al. (2002) studied this question. Intravenous amiodarone yielded a 77.6% effective rate and 8.2% side effect rate without worsening heart function in patients with congestive heart failure and rapid atrial fibrillation.
Synapse has enriched 10 related papers. Consider them for comparative context: